Clinical Trial
Humanity Neurotech Device for Long COVID Cognitive Dysfunction
This study will assess the feasibility of an at-home device treatment in patients with cognitive dysfunction related to Long COVID, and to collect data on safety and efficacy to inform the design of larger clinical studies.
Is this a virtual opportunity?
No, this is not a virtual opportunity.
What are the location requirements?
You must be located in the USA.
Will there be in-person visits? If so, how many?
Yes, there will be 3 in-person visits.
Where is the study located?
5 East 98th Street, New York, New York, USA.
What is the length of participation?
The length of participation is 8 weeks.
What health qualifications are there to participate?
Long COVID (attestation of COVID infection which caused Long COVID)
What kinds of tasks are associated with participation?
There will be blood draws, surveys, and cognitive assessments.